InspireMD, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for NSPR, updated each market day.
NSPR AI Sentiment
AI sees no strong directional signal for InspireMD, Inc. stock over the next 10 market days.
Prediction date: Sept. 21, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About InspireMD, Inc.
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
Sector
Exchange
Market Cap
$35,457,094
Cap Tier
Employees
127
Headquarters
MIAMI, FL
Listed Since
Aug. 22, 1997
Website
NSPR Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
NSPR Volatility
InspireMD, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
